Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Express Scripts
Julphar
Colorcon
Daiichi Sankyo

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 6,759,064

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,759,064
Title: Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
Abstract:The invention described herein encompasses methods and compositions of preventing or treating cancer comprising the administration of a combination of catechins and vanilloids. Compositions of catechins include but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC). In a preferred embodiment the catechins have been treated with tannase. Compositions of vanilloids include, but are not limited to vanillylamine, the head group of capsaicin. The unique compositions of the invention contain various combinations of the catechins and vanilloids, in combination with each other or other therapeutic agents and are used to treat primary and metastatic cancers in humans. The invention also encompasses various modes of administration of the therapeutic compounds, including formulations which may be used as a dietary or nutritional supplement or as a therapeutic compound.
Inventor(s): Morre ; Dorothy M. (West Lafayette, IN), Morre ; D. James (West Lafayette, IN)
Assignee: Purdue Research Foundation (West Lafayette, IN)
Application Number:10/081,903
Patent Claims:see list of patent claims

Details for Patent 6,759,064

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Purdue Research Foundation (West Lafayette, IN) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 6,759,064

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 02067966 Sep 06, 2002
World Intellectual Property Organization (WIPO) 2005058340 Jun 30, 2005
United States of America 2003072821 Apr 17, 2003
United States of America 2005031716 Feb 10, 2005
United States of America 7192612 Mar 20, 2007
Australia 2002254007 Sep 21, 2006
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
UBS
Medtronic
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.